Case report: Management of life-threatening oropharyngeal bleeding with recombinant factor VIIa

Canadian Journal of Anesthesia

Volumn 53, Issue 9, 2006, Pages 881-884

  Riazi, Sheila ^a   Karkouti, Keyvan ^a   Heggie, Jane ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

FENTANYL; FRESH FROZEN PLASMA; MIDAZOLAM; PROPOFOL; RECOMBINANT BLOOD CLOTTING FACTOR 7A; SUXAMETHONIUM;

ADULT; ANESTHESIA INDUCTION; ARTICLE; AUTOIMMUNE HEPATITIS; BLOOD CLOTTING DISORDER; BOUGIE; CASE REPORT; DIALYSIS; DROWSINESS; ENDOTRACHEAL INTUBATION; ESOPHAGUS VARICES BLEEDING; FEMALE; HUMAN; INTERNATIONAL NORMALIZED RATIO; KIDNEY FAILURE; LARYNGOSCOPY; LIVER CIRRHOSIS; LIVER FAILURE; LIVER RESECTION; LIVER TRANSPLANTATION; MANUAL VENTILATION; PHARYNX DISEASE; PHARYNX HEMORRHAGE; PLASMA TRANSFUSION; POSTOPERATIVE CARE; PRIORITY JOURNAL; THROMBOCYTE TRANSFUSION; VEIN LIGATION;

ADULT; FACTOR VII; FEMALE; HEMORRHAGE; HUMANS; INTUBATION, INTRATRACHEAL; OROPHARYNX; PHARYNGEAL DISEASES; RECOMBINANT PROTEINS;

EID: 33750724480     PISSN: 0832610X     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03022830     Document Type: Article

References (9)

1. Ramsey G. Treating coagulopathy in liver disease with plasma transfusions or recombinant factor VIIa: an evidence-based review. Best Pract Res Clin Haematol 2006; 19: 113-26.
2. Wiklund RA. Preoperative preparation of patients with advanced liver disease. Crit Care Mcd 2006; 32(Suppl.): S106-15.
3. American Society of Anesthesiologists Task Force on Management of the Difficult Airway. Practice guidelines for management of the difficult airway. An updated report by the American Society of Anesthesiologists Task Force on Management of the Difficult Airway. Anesthesiology 2003; 98: 1269-77.
4. Hedner U. Mechanism of action of recombinant activated factor VII: an update. Semin Hematol 2006; 43(Suppl 1): S105-7.
5. Welsby IJ, Monroe DM, Lawson JH, Hoffmann M. Recombinant activated factor VII and the anaesthetist. Anaesthesia 2005; 60: 1203-12.
6. Boffard KD, Riou B, Warren B, et al.; NovoSeven Trauma Study Group. Recombinant factor VIIa as adjunctive therapy for bleeding control in severely injured trauma patients: two parallel randomized, placebo-controlled, double-blind clinical trials. J Trauma 2005; 59: 8-15.
7. Karkouti K, Beattie WS, Wijeysundera DN, et al. Recombinant factor VIIa for intractable blood loss after cardiac surgery: a propensity-score matched case-control analysis. Transfusion 2005; 45: 26-34.
8. Laguna P, Klukowska A. Management of oral bleedings with recombinant factor VIIa in children with haemophilia A and inhibitor. Haemophilia 2005; 11: 2-4.
9. Morimoto Y, Yoshioka A, Shima M, Kirita T. Intraoral hemostasis using a recombinant activated factor VII preparation in a hemophilia A patient with inhibitor. J Oral Maxillofac Surg 2003; 61: 1095-7.